BoneMarrowR2
Precise bone marrow iron measurement for clinical studies
Software · Cloud SaaSCompany source
Company profile
About Resonance Health Analysis Services Pty Ltd
Resonance Health Analysis Services Pty Ltd is an Australian medical imaging company specialising in advanced MRI-based analysis solutions for liver and cardiac assessment. The company develops and delivers non-invasive imaging technologies that empower physicians to enhance clinical decision-making, tailor patient care, and achieve superior outcomes. Their comprehensive product portfolio includes FerriScan® and FerriSmart® for liver iron concentration analysis, HepaFatScan® and HepaFatSmart® for liver fat assessment, LiverSmart® for combined liver metrics, and Cardiac T2* technology for heart iron assessment. These solutions utilise both AI-powered automated analysis engines and expert physicist review at their Core Laboratory. Resonance Health serves clinicians, radiologists, and imaging providers globally, with validated MRI clinic networks and secure DICOM transfer via their FAST portal. The company also manufactures high-quality phantoms for MRI scanner calibration and quality assurance. Their investigational products include organ volume measurements for liver and spleen, bone marrow R2 analysis, and brain iron assessment tools for clinical research applications. Based in Burswood, Western Australia, Resonance Health is publicly traded and maintains a strong commitment to research and development, continuous improvement, and evidence-based clinical solutions.
Company description Resonance Health Analysis Services Pty Ltd official website
Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Resonance Health Analysis Services Pty Ltd?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Cardiac iron overload
- Hemochromatosis
- Liver iron overload
- Liver steatosis/fatty liver disease
- Sickle cell disease
- Thalassemia
Who it serves
- Clinical Trial Sites
- Clinicians
- Health Systems
- Imaging Providers
- MRI Centers
- Radiologists
Deployment & integration
Cloud Saas · On Premise deployment with recorded integration context.
Geographic context
MarketsAustralia · Global (validated clinic networks worldwide)
Company sourceOfficial website
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Cardiac T2*
Widely accepted MRI-based heart iron assessment
Service · Cloud SaaSCompany source
FAST Portal
Secure DICOM file transmission and results delivery platform
Platform · Cloud SaaSCompany source
FerriScan®
MRI-based liver iron concentration analysis with expert physicist review
Service · Cloud SaaSCompany source
FerriSmart®
AI-powered real-time liver iron concentration analysis
Software · Cloud SaaSCompany source
HepaFatScan®
Expert-reviewed MRI-based liver fat assessment
Service · Cloud SaaSCompany source
HepaFatSmart®
AI-powered automated multi-metric liver fat assessment
Software · Cloud SaaSCompany source
LiverSmart®
Combined AI-powered liver iron and fat assessment
Software · Cloud SaaSCompany source
MRI Phantoms
High-quality phantoms for MRI calibration and quality assurance
Device · On PremiseCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
No linked records are currently available.
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
HepaFatSmart (V2.0.0)K231459 · 510k · Jun 20, 2023
LiverSmartK213776 · 510k · Dec 29, 2021
HepaFat-AIK201039 · 510k · Dec 7, 2020
FerriSmart Analysis SystemK182218 · 510k · Nov 30, 2018
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Real-time results generation
AI-powered products deliver results immediately vs 2 business days for manual analysis
Non-invasive assessment
MRI-based methods eliminate need for liver biopsy
High reliability
Liver iron concentration analysis with validated accuracy
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Resonance Health Analysis Services Pty Ltd
Recent articles published on Resonance Health Analysis Services Pty Ltd's official website.
Balancing Act: Understanding Iron and Iron Overload in Your Body
Read on Resonance Health Analysis Services Pty LtdThe Future of Magnetic Resonance Imaging: A Conversation with Professor Tim St Pierre
Read on Resonance Health Analysis Services Pty LtdAdvancements in MRI Measurements for Tissue Iron
Read on Resonance Health Analysis Services Pty LtdAn MRI Based Non-invasive Biomarker for Quantifying Liver Fibrosis and Inflammation Without Additional Equipment and Contrast Agent
Read on Resonance Health Analysis Services Pty LtdExploring Non-Invasive Methods to Measure Liver Iron Concentration
Read on Resonance Health Analysis Services Pty Ltd07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Medical Imaging & Radiology
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.